215 related articles for article (PubMed ID: 2653929)
1. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
Taskinen MR; Sane T; Helve E; Karonen SL; Nikkilä EA; Yki-Järvinen H
Diabetes; 1989 May; 38(5):580-8. PubMed ID: 2653929
[TBL] [Abstract][Full Text] [Related]
2. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM.
Saloranta C; Taskinen MR; Widen E; Härkönen M; Melander A; Groop L
Diabetes; 1993 Nov; 42(11):1559-66. PubMed ID: 8405695
[TBL] [Abstract][Full Text] [Related]
3. Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.
Yki-Järvinen H; Helve E; Sane T; Nurjhan N; Taskinen MR
Am J Physiol; 1989 Jun; 256(6 Pt 1):E732-9. PubMed ID: 2660587
[TBL] [Abstract][Full Text] [Related]
4. Comparison of acute daytime and nocturnal insulinization on diurnal glucose homeostasis in NIDDM.
Puhakainen I; Taskinen MR; Yki-Järvinen H
Diabetes Care; 1994 Aug; 17(8):805-9. PubMed ID: 7956622
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the nocturnal free fatty acid levels by bedtime cornstarch in NIDDM subjects.
Axelsen M; Lönnroth P; Arvidsson Lenner R; Smith U
Eur J Clin Invest; 1997 Feb; 27(2):157-63. PubMed ID: 9061310
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production.
Boden G; Chen X; Urbain JL
Diabetes; 1996 Aug; 45(8):1044-50. PubMed ID: 8690150
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM.
Puhakainen I; Yki-Järvinen H
Diabetes; 1993 Dec; 42(12):1694-9. PubMed ID: 8243814
[TBL] [Abstract][Full Text] [Related]
8. Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
Nielsen MF; Wise S; Dinneen SF; Schwenk WF; Basu A; Rizza RA
Diabetes; 1997 Dec; 46(12):2007-16. PubMed ID: 9392488
[TBL] [Abstract][Full Text] [Related]
9. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin.
Abbasi F; Carantoni M; Chen YD; Reaven GM
Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437
[TBL] [Abstract][Full Text] [Related]
11. Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR; Dalsky GP; Clutter WE; Shah SD; Holloszy JO; Cryer PE
J Clin Invest; 1986 Jan; 77(1):212-21. PubMed ID: 3511090
[TBL] [Abstract][Full Text] [Related]
12. Strict nocturnal diabetic control diminishes subsequent glycemic escape during acute insulin withdrawal.
Vaughan NJ; Rao RH; Kurtz AB; Buckell HM; Spathis GS
Metabolism; 1986 Feb; 35(2):136-42. PubMed ID: 3511351
[TBL] [Abstract][Full Text] [Related]
13. Impaired modulation of hepatic glucose output overnight after a 72-h fast in normal man.
Clore JN; Helm ST; Nestler JE; Blackard WG
J Clin Endocrinol Metab; 1990 Apr; 70(4):865-8. PubMed ID: 2180979
[TBL] [Abstract][Full Text] [Related]
14. The effects of superphysiologic hyperinsulinemia on glucose and lipid metabolism in glucose-tolerant offspring of patients with non-insulin-dependent diabetes mellitus (NIDDM).
Osei K
Diabetes Res Clin Pract; 1992 Sep; 17(3):169-82. PubMed ID: 1425156
[TBL] [Abstract][Full Text] [Related]
15. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
[TBL] [Abstract][Full Text] [Related]
16. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Groop LC; Bonadonna RC; DelPrato S; Ratheiser K; Zyck K; Ferrannini E; DeFronzo RA
J Clin Invest; 1989 Jul; 84(1):205-13. PubMed ID: 2661589
[TBL] [Abstract][Full Text] [Related]
17. Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Basu R; Basu A; Nielsen M; Shah P; Rizza RA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2314-9. PubMed ID: 10404795
[TBL] [Abstract][Full Text] [Related]
18. Contribution of cortisol to glucose counterregulation in humans.
De Feo P; Perriello G; Torlone E; Ventura MM; Fanelli C; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
Am J Physiol; 1989 Jul; 257(1 Pt 1):E35-42. PubMed ID: 2665516
[TBL] [Abstract][Full Text] [Related]
19. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
[TBL] [Abstract][Full Text] [Related]
20. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
